Analyze Diet

The effect of recombinant human fibroblast growth factor-18 on articular cartilage following single impact load.

Abstract: The aim of this in vitro study was to ascertain the effect of recombinant human Fibroblast Growth Factor-18 (rhFGF18) on the repair response of mechanically damaged articular cartilage. Articular cartilage discs were harvested from healthy mature horses (n = 4) and subjected to single impact load (SIL). The impacted explants, together with unimpacted controls were cultured in modified DMEM ± 200 ng/ml rhFGF18 for up to 30 days. Glycosaminoglycan (GAG) release into the media was measured using the dimethylmethylene blue (DMMB) assay. Aggrecan neopepitope CS846, collagen type II synthesis (CPII) and cleavage (C2C) were measured by ELISA. Histological analysis and TUNEL staining were used to assess repair cell number and cell death. Impacted explants treated with rhFGF18 showed significantly more GAG and CS846 release into the media (p < 0.05), there was also a significant decrease in C2C levels at Day 20. Loaded sections treated with rhFGF18 had more repair cells and significantly less cell death (p < 0.001) at Day 30 in culture. In an in vitro damage/repair model, rhFGF18 increases the proteoglycan synthesis, the repair cell number and prevents apoptosis at Day 30. This suggests that rhFGF18 may be a good candidate for enhancement of cartilage repair following mechanical damage.
Publication Date: 2014-04-09 PubMed ID: 24719286DOI: 10.1002/jor.22622Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study explores the effect of a substance known as recombinant human Fibroblast Growth Factor-18 (rhFGF18) on the regeneration of damaged articular cartilage, as seen in conditions such as arthritis. The results indicate that this substance may boost tissue repair, enhancing the presence of helpful cells and key compounds and reducing cell death.

Research Methodology

  • The approaching method for this study involved using in vitro, or laboratory, techniques to observe how rhFGF18 affects cartilage repair. Cartilage discs were obtained from healthy adult horses and subjected to a single incident of mechanical load to simulate injury.
  • The researchers then cultured these damaged and control cells in a modified version of DMEM (Dulbecco’s Modified Eagle Medium), a nutritional mixture used in biology to support growth in a laboratory environment. These were either combined with rhFGF18, or not, for up to 30 days.

Monitoring Repair Progress

  • To track the effectiveness of repair, the team measured Glycosaminoglycan (GAG) release into the culture medium. GAGs are crucial components of cartilage tissue, and increased release usually indicates successful repair.
  • Other markers of cartilage health, like the appearance of new Aggrecan epitopes (CS846), and the generation and breakdown of collagen type II (CPII and C2C respectively), were also monitored using an enzyme-linked diagnostic method (ELISA).
  • Histological examination (studying the microscopic anatomy of cells and tissues) and TUNEL staining, a technique to measure cell death, were used to calculate repair cell numbers and assess whether there was an increase in cell death.

Results and Significance

  • In the case of the damaged samples treated with rhFGF18, there was a significant increase in GAG and CS846 release, indicating successful repair. Additionally, there was a noticeable decrease in the levels of collagen breakdown (C2C levels) by Day 20.
  • The study also observed that rhFGF18 treatment resulted in a higher number of repair cells and significantly less cell death by Day 30, suggesting a protective effect.
  • The in vitro model suggests that rhFGF18 enhances proteoglycan synthesis (which would support cartilage health), the number of repair cells and prevents apoptosis (cell death) at 30 days, implying that rhFGF18 could be a promising agent for boosting the repair of cartilage after damage.

Cite This Article

APA
Barr L, Getgood A, Guehring H, Rushton N, Henson FM. (2014). The effect of recombinant human fibroblast growth factor-18 on articular cartilage following single impact load. J Orthop Res, 32(7), 923-927. https://doi.org/10.1002/jor.22622

Publication

ISSN: 1554-527X
NlmUniqueID: 8404726
Country: United States
Language: English
Volume: 32
Issue: 7
Pages: 923-927

Researcher Affiliations

Barr, Lynne
  • Orthopaedic Research Unit, Department of Surgery, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, United Kingdom.
Getgood, Alan
    Guehring, Hans
      Rushton, Neil
        Henson, Frances M D

          MeSH Terms

          • Aggrecans / metabolism
          • Animals
          • Apoptosis
          • Cartilage, Articular / drug effects
          • Cartilage, Articular / injuries
          • Cartilage, Articular / metabolism
          • Cell Death
          • Collagen Type II / metabolism
          • Culture Media / chemistry
          • Epitopes / metabolism
          • Fibroblast Growth Factors / pharmacology
          • Glycosaminoglycans / metabolism
          • Horses
          • Humans
          • Recombinant Proteins / pharmacology
          • Stress, Mechanical
          • Time Factors
          • Wound Healing / drug effects

          Citations

          This article has been cited 15 times.
          1. Aramini B, Masciale V, Radaelli LFZ, Sgarzani R, Dominici M, Stella F. The sternum reconstruction: Present and future perspectives. Front Oncol 2022;12:975603.
            doi: 10.3389/fonc.2022.975603pubmed: 36387077google scholar: lookup
          2. Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mech Dis 2022 Jul;14(4):e1549.
            doi: 10.1002/wsbm.1549pubmed: 35142107google scholar: lookup
          3. Shestovskaya MV, Bozhkova SA, Sopova JV, Khotin MG, Bozhokin MS. Methods of Modification of Mesenchymal Stem Cells and Conditions of Their Culturing for Hyaline Cartilage Tissue Engineering. Biomedicines 2021 Nov 11;9(11).
            doi: 10.3390/biomedicines9111666pubmed: 34829895google scholar: lookup
          4. Hendesi H, Stewart S, Gibison ML, Guehring H, Richardson DW, Dodge GR. Recombinant fibroblast growth factor-18 (sprifermin) enhances microfracture-induced cartilage healing. J Orthop Res 2022 Mar;40(3):553-564.
            doi: 10.1002/jor.25063pubmed: 33934397google scholar: lookup
          5. Xie Y, Zinkle A, Chen L, Mohammadi M. Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nat Rev Rheumatol 2020 Oct;16(10):547-564.
            doi: 10.1038/s41584-020-0469-2pubmed: 32807927google scholar: lookup
          6. Riegger J, Brenner RE. Pathomechanisms of Posttraumatic Osteoarthritis: Chondrocyte Behavior and Fate in a Precarious Environment. Int J Mol Sci 2020 Feb 25;21(5).
            doi: 10.3390/ijms21051560pubmed: 32106481google scholar: lookup
          7. Reker D, Kjelgaard-Petersen CF, Siebuhr AS, Michaelis M, Gigout A, Karsdal MA, Ladel C, Bay-Jensen AC. Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo. J Transl Med 2017 Dec 12;15(1):250.
            doi: 10.1186/s12967-017-1356-8pubmed: 29233174google scholar: lookup
          8. Riegger J, Joos H, Palm HG, Friemert B, Reichel H, Ignatius A, Brenner RE. Striking a new path in reducing cartilage breakdown: combination of antioxidative therapy and chondroanabolic stimulation after blunt cartilage trauma. J Cell Mol Med 2018 Jan;22(1):77-88.
            doi: 10.1111/jcmm.13295pubmed: 28834244google scholar: lookup
          9. Diao X, Li Z, An B, Xin H, Wu Y, Li K, Feng F, Dou C. The Microdamage and Expression of Sclerostin in Peri-implant Bone under One-time Shock Force Generated by Impact. Sci Rep 2017 Jul 26;7(1):6508.
            doi: 10.1038/s41598-017-06867-9pubmed: 28747741google scholar: lookup
          10. Goldring MB, Berenbaum F. Emerging targets in osteoarthritis therapy. Curr Opin Pharmacol 2015 Jun;22:51-63.
            doi: 10.1016/j.coph.2015.03.004pubmed: 25863583google scholar: lookup
          11. Carter TE, Taylor KA, Spritzer CE, Utturkar GM, Taylor DC, Moorman CT 3rd, Garrett WE, Guilak F, McNulty AL, DeFrate LE. In vivo cartilage strain increases following medial meniscal tear and correlates with synovial fluid matrix metalloproteinase activity. J Biomech 2015 Jun 1;48(8):1461-8.
          12. Caldwell KL, Wang J. Cell-based articular cartilage repair: the link between development and regeneration. Osteoarthritis Cartilage 2015 Mar;23(3):351-62.
            doi: 10.1016/j.joca.2014.11.004pubmed: 25450846google scholar: lookup
          13. Xia B, Di Chen, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int 2014 Dec;95(6):495-505.
            doi: 10.1007/s00223-014-9917-9pubmed: 25311420google scholar: lookup
          14. Li HZ, Zhang JL, Yuan DL, Xie WQ, Ladel CH, Mobasheri A, Li YS. Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family. Mil Med Res 2024 Jun 21;11(1):40.
            doi: 10.1186/s40779-024-00544-5pubmed: 38902808google scholar: lookup
          15. Hollander JM, Goraltchouk A, Rawal M, Liu J, Luppino F, Zeng L, Seregin A. Adeno-Associated Virus-Delivered Fibroblast Growth Factor 18 Gene Therapy Promotes Cartilage Anabolism. Cartilage 2023 Dec;14(4):492-505.
            doi: 10.1177/19476035231158774pubmed: 36879540google scholar: lookup